|
|
 | | | |
- close
- close
- close
- close
Savient Pharmaceuticals (SVNT) |
QUOTE AND NEWS
Benzinga
May 9
Comment
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that it has completed the financing and debt restructuring transactions contemplated by certain Exchange and Purchase Agreements, dated May 7, 2012, between the Company and certain...
MarketWatch
May 9
Comment
Shares of Savient Pharmaceuticals fell 10% to $1.63 on Wednesday after it released a weaker-than-expected earnings report. The stock jumped nearly 20% on Tuesday on news that it had reached an agreement with certain creditors to restructure a...
StreetInsider.com
May 9
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Savient+Pharmaceuticals+%28SVNT%29+Misses+All+Q1+Expectations/7417817.html for the full story.
PR Newswire
May 9
Comment
EAST BRUNSWICK, N.J., May 9, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three months ended March 31, 2012, which reflects the Company's continuing commercialization of KRYSTEXXA®
MarketWatch
May 8
Comment
Shares of Savient Pharmaceuticals jumped 19% to $1.85 Tuesday on news that it reached an agreement with some of its creditors to restructure a portion of its debt. The agreement involves certain holders of its 4.75% convertible senior notes...
StreetInsider.com
May 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Savient+Pharma+%28SVNT%29+Enters+Debt+Restructuring%2C+Financing+Agreements/7411828.html for the full story.
Marketwire
May 4
Comment
NEW YORK, NY -- (Marketwire) -- 05/04/12 -- Biotech stocks have continued to provide investors with strong gains in 2012. The iShares NASDAQ Biotechnology Index (IBB) is up nearly 20 percent year-to-date. The passage of the America Invents Act will
PR Newswire
May 3
Comment
EAST BRUNSWICK, N.J., May 3, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the Company will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Thursday, May 17, 2012, at 11:20 a.m. PT.
FierceBiotech
May 2
Comment
John Johnson has a good reason today to be thankful for his new job at Dendreon: He won't have to face the music at Savient, where his former colleagues will be grappling with a high-profile lawsuit from a West Coast hedge fund claiming that the...
TheStreet.com
May 1
Comment
="Scripts/swfobject_modified.js" type="text/javascript">if !IE-->endif-->Content on this page requires a newer version of Adobe Flash Player.
if !IE-->endif-->
EAST BRUNSWICK, NJ (TheStreet) --
Savient Pharmaceuticals is insolvent and its...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
